The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Viral Hepatitis, Type B: Studies on Natural History and Prevention Re-Examined
Abstract
Frozen serial serum specimens obtained from past studies on the natural history and prevention of Type B hepatitis in children were retested by radioimmunoassay for the following markers of hepatitis B infection: hepatitis B surface antigen (HBsAg) and antibody (anti-HBs), hepatitis B e antigen (HBeAg) and antibody (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc). The interval between exposure and evidence of viremia (HBsAg) was as short as six days. HBsAg and HBeAg persisted for two to five months and occasionally for more than one year after recovery. After the disappearance of their respective antigens, anti-HBc and anti-HBs persisted for more than seven years and anti-HBe for one to two years. Treatment with hepatitis B immune globulin after exposure induced complete or partial protection or prolongation of the incubation period. Administration of heat-inactivated hepatitis B virus, MS-2 strain, to 29 children induced an inapparent infection in three, characterized by a transient appearance of HBsAg and HBeAg, and the persistence of anti-HBc, anti-HBe and anti-HBs for more than two years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TRANSAMINASE ACTIVITY IN HUMAN BLOOD
Karmen, A., Wróblewski, F., & LaDue, J. S. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103055 · Cited by 1,708
Krugman, S. (1967) · JAMA · doi:10.1001/jama.200.5.365 · Cited by 556
Self-citationHemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis
Vyas, G. N., & Shulman, N. R. (1970) · Science · doi:10.1126/science.170.3955.332 · Cited by 479
Prevalence of Hepatitis B Virus Antigen As Revealed by Direct Radioimmune Assay with 125I-Antibody
Ling, C. M., & Overby, L. R. (1972) · The Journal of Immunology · doi:10.4049/jimmunol.109.4.834 · Cited by 402
Self-citationViral hepatitis. New light on an old disease
Krugman, S. (1970) · JAMA · doi:10.1001/jama.212.6.1019 · Cited by 348
Self-citationANTIBODY TO HEPATITIS-B-VIRUS CORE IN MAN
Hoofnagle, J., Gerety, R., & Barker, L. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92004-7 · Cited by 337
Viral Hepatitis, Type B (MS-2-Strain): Further Observations on Natural History and Prevention
Krugman, S., & Giles, J. P. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304122881503 · Cited by 196
Self-citationViral hepatitis: clinical aspects
REDEKER, A. G. (1975) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197507000-00003 · Cited by 183
Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays
Mushahwar, I. K., Overby, L. R., Frösner, G., Deinhardt, F. W., & Ling, C. (1978) · Journal of Medical Virology · doi:10.1002/jmv.1890020202 · Cited by 94
Self-citation
Cited by
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,148
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,061
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
“The average incubation period is 60 days (range: 40–90 days) from exposure to onset of abnormal serum ALT levels and 90 days (range: 60–150 days) from exposure to onset of jaundice (8,42,43).”
Background(2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 753
Metadata
- Authors
- Krugman, S., Overby, L. R., Mushahwar, I. K., Ling, C.-M., Frösner, G. G., & Deinhardt, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1979-01-18
- Volume
- 300
- Issue
- 3
- Pages
- 101-106
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2067817601
- Cited by
- 266
- References
- 9
- FWCI
- 29.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Viral Hepatitis, Type B: Studies on Natural History and Prevention Re-Examined. https://app.cochat.ai/papers/10.1056/nejm197901183000301
- The paper
- Krugman, S., Overby, L. R., Mushahwar, I. K., Ling, C.-M., Frösner, G. G., & Deinhardt, F. (1979). Viral Hepatitis, Type B: Studies on Natural History and Prevention Re-Examined. New England Journal of Medicine. https://doi.org/10.1056/nejm197901183000301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.